Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by BioTeckon Jul 29, 2022 11:59am
266 Views
Post# 34860210

RE:RE:RE:RE:RE:RE:A very bad sign

RE:RE:RE:RE:RE:RE:A very bad signThere is nothing happening until 2024. This is going to trade flat or slowly trickle down sub dollar and fluctuate with general market conditions. 

The only thing they could do if they had any sort of brains would be to release preclinical data on conformal coating. Find patient #7 and implant them with the larger pouch and let people know it's been done. Start the thyroid clinical. 

Instead Phil is jet setting around the world with his new pal Barney wining and dining on the company card. These so called roadshows were supposed to help with liquidity but we are about as liquid as ice. Sell this POS company to the lowest bidder so we can rid our shares.




Metalsguy1 wrote:
The level of ineptitude at the company continues. The chart reflects that. Only incompetence could take a company like SVA and trash their own stock price in drastically lower highs and lower lows with so little interest from buyers in what should be the hottest sector right now. The BoD surely must be liable for such gross incompetence.


<< Previous
Bullboard Posts
Next >>